Schedule 13G ownership disclosure

Braveheart Bio Inc

Common Stock, par value $0.0001 per share · CUSIP: 10567X101

Event date: 2026-09-30

Filing-level shares
7,420,091.00
Percent of class
8.2%
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd.

    Shares: 7,420,091.00 · Class: 8.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-124063
Form type
SCHEDULE 13G
Filer
Braveheart Bio, Inc.
CIK
CIK 2131524
Filed
Nov 09, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub